Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, United States of America.
Anti-Filariasis Campaign, Ministry of Health, Nutrition and Indigenous Medicine, Colombo, Sri Lanka.
PLoS Negl Trop Dis. 2019 Apr 22;13(4):e0007365. doi: 10.1371/journal.pntd.0007365. eCollection 2019 Apr.
Sri Lanka's Anti-Filariasis Campaign conducted 5 annual rounds of mass drug administration (MDA) with diethylcarbamazine (DEC) plus albendazole to eliminate lymphatic filariasis (LF) in all endemic districts between 2002 and 2006. Post-MDA surveillance has consistently documented Wuchereria bancrofti microfilaremia (Mf) rates below 1% in all sentinel and spot check sites since that time, and all implementation units easily satisfied WHO's target for school-based transmission assessment surveys (school-TAS) in 2013. However, more detailed studies have identified foci of persistent infection in the large coastal evaluation unit (EU) (population about 0.6 million) in Galle district. Therefore, the purpose of this study was to assess the sensitivity and feasibility of community-based TAS in adults (adult-TAS) and to compare results obtained by adult-TAS with prior school-TAS and molecular xenomonitoring (MX, molecular detection of filarial DNA in systematically sampled mosquitoes) results in this known problem area.
Two cluster surveys were performed in independent samples of 30 evaluation areas (EAs) in the coastal Galle EU in 2015. Each survey tested approximately 1,800 adults for circulating filarial antigenemia (CFA) with the Alere Filariasis Test Strip. The CFA prevalence for all persons tested (N = 3,612) was 1.8% (CI 1.4-2.2), and this was significantly higher than the CFA rate of 0.4% obtained by school-TAS in 2013. CFA prevalences in the two samples were similar [1.5% (CI 1.0-2.2), and 2.0% (CI 1.4-2.7)]. Antigenemia prevalence in sampled EUs was highly variable (range 0-11%), and it exceeded 5% in 6 EAs. The 30 EAs sampled in one of our adult-TAS surveys had recently been assessed for persistent filariasis by molecular xenomonitoring (MX). CFA prevalence in adults and filarial DNA prevalence in mosquitoes in these EAs were significantly correlated (r = 0.43; P = 0.02).
Community based adult-TAS provided a reproducible measure of persistent W. bancrofti infection in a large evaluation unit in Sri Lanka that has low-level persistence of LF following multiple rounds of MDA. In addition, adult-TAS and MX results illustrate the focality of persistent LF in this setting. Adult-TAS may be more sensitive than school-TAS for this purpose. Adult-TAS and MX are potential options for post-MDA and post-validation surveillance programs to identify problem areas that require mop-up activities. Adult-TAS should also be useful for remapping areas with uncertain LF endemicity for possible inclusion in national LF elimination programs.
斯里兰卡的抗丝虫病运动在 2002 年至 2006 年间在所有流行地区进行了 5 轮年度大规模药物治疗(MDA),使用乙胺嗪(DEC)加阿苯达唑来消除淋巴丝虫病(LF)。自那时以来,MDA 后的监测一直记录到所有哨点和抽查点的班氏丝虫微丝蚴血症(Mf)率均低于 1%,所有实施单位在 2013 年轻松满足了世界卫生组织(WHO)对学校为基础的传播评估调查(school-TAS)的目标。然而,更详细的研究在加勒区的大型沿海评估单位(EU)(约 600 万人口)中发现了持续感染的焦点。因此,本研究的目的是评估基于社区的成年人 TAS(adult-TAS)的敏感性和可行性,并将 adult-TAS 的结果与之前的 school-TAS 和分子 xenomonitoring(MX,系统采样的蚊子中丝状 DNA 的分子检测)结果进行比较在这个已知的问题区域。
2015 年在加勒 EU 的两个独立的 30 个评估区(EA)样本中进行了两次聚类调查。每个调查用 Alere Filariasis Test Strip 测试了大约 1800 名成年人的循环丝虫抗原血症(CFA)。所有接受测试的人的 CFA 患病率(N = 3612)为 1.8%(CI 1.4-2.2),这明显高于 2013 年 school-TAS 获得的 0.4%的 CFA 率。两个样本的 CFA 患病率相似[1.5%(CI 1.0-2.2)和 2.0%(CI 1.4-2.7)]。抽样 EU 的抗原血症患病率变化很大(范围 0-11%),有 6 个 EU 的患病率超过 5%。我们的一次 adult-TAS 调查中抽样的 30 个 EA 最近通过分子 xenomonitoring(MX)进行了持久性丝虫病评估。这些 EA 中成年人的 CFA 患病率和蚊子中的丝虫 DNA 患病率呈显著相关(r = 0.43;P = 0.02)。
基于社区的成年人 TAS 为斯里兰卡一个大型评估单位提供了一种可重复的、持久性 W. bancrofti 感染的衡量标准,该单位在多次 MDA 后仍存在低度 LF 持续性。此外,成人 TAS 和 MX 的结果说明了这种情况下 LF 的局灶性。在这方面,成人 TAS 可能比 school-TAS 更敏感。成人 TAS 和 MX 是 MDA 后和验证后监测计划的潜在选择,可以识别需要清理活动的问题区域。成人 TAS 也应该有助于重新绘制不确定 LF 流行地区的地图,以便可能纳入国家 LF 消除计划。